Cracking the Code: Understanding Your Pathology Report

The pathology report is the most important document in your medical record. It is the definitive “blueprint” of your cancer, detailing exactly what the cells look like and how far they have traveled ^[1]. Understanding this report allows you to participate as an active partner in your care.

When Does the Pathology Report Happen?

Unlike breast or prostate cancer, where a needle biopsy is almost always the first step, RCC is frequently diagnosed and sent straight to surgery based only on the results of a CT or MRI scan ^[2][3]. This is completely normal. Scans are often accurate enough that doctors do not need to risk a needle biopsy before removing the tumor. Therefore, your comprehensive pathology report usually comes after surgery.

However, if you are not a candidate for surgery, are considering active surveillance, or have cancer that has already spread (metastatic disease), your doctor may perform a renal mass biopsy ^[4]. In this procedure, a thin needle is used to extract a small sample of the tumor to create a pathology report and guide your systemic treatment choices ^[5].

The Standard: WHO/ISUP Grading

For many years, doctors used the Fuhrman grading system to describe how aggressive kidney cancer cells looked. However, this has been replaced by the WHO/ISUP grading system ^[6].

The WHO/ISUP system is the new international standard because it is more consistent and better at predicting how a tumor will behave ^[6]. It grades cells from 1 to 4 based on the size and visibility of the nucleoli (the “command centers” inside the cell’s nucleus) ^[6]:

• Grade 1: Tiny, hard-to-see nucleoli; usually slow-growing.
• Grade 2: Nucleoli are visible under a high-power microscope.
• Grade 3: Nucleoli are clearly visible even at low power.
• Grade 4: Characterized by extreme cellular changes (pleomorphism) and/or the presence of highly aggressive sarcomatoid or rhabdoid features (see below) ^[6].

If your report still uses the Fuhrman system, you may want to ask your doctor if a pathologist can re-review the tissue using the WHO/ISUP standards ^[6].

High-Risk Features: What to Watch For

Beyond the grade, there are specific “red flag” features that must be documented because they significantly change the treatment plan:

1. Sarcomatoid and Rhabdoid Features: These are not different types of cancer, but rather a way that RCC cells “transform” into a more aggressive, fast-growing shape ^[7][8]. Tumors with these features are automatically considered Grade 4 ^[6]. Interestingly, tumors with sarcomatoid features often respond very well to immunotherapy ^[9][10].
2. Tumor Necrosis: This refers to areas of dead cancer cells within the tumor ^[11]. Its presence suggests the tumor was growing so fast it outstripped its own blood supply. Necrosis is a key marker of a more aggressive tumor ^[12][13].
3. Margins: A “negative margin” means no cancer cells were found at the very edge of the tissue the surgeon removed. This is the goal of surgery ^[14].

Staging Your Cancer (TNM)

While “grade” describes the look of the cells, stage describes the extent of the cancer in your body. Doctors use the TNM system ^[15]:

• T (Tumor): Ranges from T1 (small, limited to the kidney) to T4 (growing into nearby organs) ^[15]. A key stage is T3a, where the tumor has reached the renal vein or the fat surrounding the kidney, even if the tumor itself is small ^[16].
• N (Nodes): N0 means no cancer in nearby lymph nodes; N1 means cancer was found there ^[15].
• M (Metastasis): M0 means no distant spread; M1 means the cancer has traveled to other parts of the body, like the lungs or bones ^[15].

Pathology Report Checklist

Use this checklist to ensure your report is complete. If these items are missing, you can request an addendum (a formal update to the report) ^[1][17]:

• [ ] Histological Type (e.g., Clear Cell, Papillary)
• [ ] WHO/ISUP Grade (1 through 4)
• [ ] Tumor Size (measured in centimeters)
• [ ] Margins (Status of the edges)
• [ ] Sarcomatoid/Rhabdoid Features (Should state if present or absent)
• [ ] Tumor Necrosis (Should state if present or absent)
• [ ] Lymphovascular Invasion (Whether cancer is seen in small blood or lymph vessels)